IMC-I109V

· Immunocore Ltd

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for IMC-I109V, covering 2024-10-15 to 2024-10-15. Get the full timeline:

Most recent: Clinical Trial Update: Study of IMC-I109V in Non-cirrhotic HBeAg-negative Chronic HBV Infection [Phase 1]